🔎 Trials Near Me

Hem › Bröstcancer › District of Columbia

Kliniska studier för Bröstcancer i District of Columbia

28 studier för Bröstcancer söker deltagare vid platser i District of Columbia.

Städer i District of Columbia

Officiell studietext (engelska)

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

  • Georgetown University Medical Center, Washington D.C.
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 5 okt. 2026 · NCT06982521

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

  • Georgetown University Lombardi Cancer Center, Washington D.C.
RekryterarFas 3
Ålder 18 till 100 · Alla kön · Uppdaterad 2 okt. 2026 · NCT05827081

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 40 till 75 · Alla kön · Uppdaterad 2 okt. 2026 · NCT05334069

Older Breast Cancer Patients: Risk for Cognitive Decline

  • Georgetown University, Washington D.C.
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 60 till 105 · Kvinnor · Uppdaterad 28 sep. 2026 · NCT03451383

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

  • The George Washington Medical facility Associates, Washington D.C.
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07007559

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  • MedStar Washington Hospital Center, Washington D.C.
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07174336

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

  • Georgetown Uni Hospital, Washington D.C.
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 21 sep. 2026 · NCT05894239

Identifying Patterns in the Breath of Individuals With Breast Cancer

  • GW Comprehensive Breast Center, Washington D.C.
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 40 till 74 · Kvinnor · Uppdaterad 18 sep. 2026 · NCT06512350

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

  • Georgetown University Medical Center, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
  • Sibley Memorial Hospital, Washington D.C.
  • och 1 fler
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 15 sep. 2026 · NCT06492616

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

  • MedStar Heart & Vascular Institute (MHVI) - MedStar Washington Hospital Center, Washington D.C.
RekryterarFas 1
Ålder 18 till 55 · Kvinnor · Uppdaterad 9 sep. 2026 · NCT07310420

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

  • Georgetown University, Washington D.C.
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 4 sep. 2026 · NCT05315700

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  • Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
  • och 2 fler
RekryterarFas 3
Ålder 18 till 60 · Kvinnor · Uppdaterad 2 sep. 2026 · NCT05879926

TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd

  • Georgetown University Medical Center, Washington D.C.
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 26 aug. 2026 · NCT06533826

Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming

  • Sibley Memorial Hospital, Washington D.C.
Rekryterar
Ålder 18 och äldre · Kvinnor · Uppdaterad 21 aug. 2026 · NCT06536881

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

  • Sibley Memorial Hospital, Washington D.C.
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 17 aug. 2026 · NCT06500481

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

  • Johns Hopkins Medicine - Kimmel Cancer Center-Sibley Memorial Hospital, Washington D.C.
RekryterarFas 3
Ålder 18 till 100 · Alla kön · Uppdaterad 6 aug. 2026 · NCT05232916

E-Mindfulness Approaches for Living After Breast Cancer

  • Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
RekryterarFas 3
Ålder 18 till 50 · Alla kön · Uppdaterad 4 aug. 2026 · NCT06748222

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

  • Georgetown University Medical Center, Washington D.C.
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 6 maj 2026 · NCT01042379

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

  • MedStar Washington Hospital Center, Washington D.C.
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 6 maj 2026 · NCT07062965

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
  • George Washington University Medical Center, Washington D.C.
RekryterarFas 3
Ålder 50 till 70 · Alla kön · Uppdaterad 23 apr. 2026 · NCT04852887

Cancer Experience Registry (CER) for Cancer Patients and Caregivers

  • Cancer Support Community Research & Training Institute, Washington D.C.
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 18 och äldre · Alla kön · Uppdaterad 23 apr. 2026 · NCT02333604

Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer

  • Georgetown University, Washington D.C.
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 9 apr. 2026 · NCT04841148

Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)

  • George Washington-Medical Faculty Associates, Washington D.C.
RekryterarFas 2
Ålder 21 och äldre · Alla kön · Uppdaterad 3 mars 2026 · NCT06806930

The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer

  • Sibley Memorial Hospital, Washington D.C.
Rekryterar
Ålder 18 och äldre · Kvinnor · Uppdaterad 23 feb. 2026 · NCT05780814

Study in Patients With Breast Cancer Leptomeningeal Metastasis

  • Sibley Memorial Hospital, Washington D.C.
RekryterarObservationsstudie
18 Weeks · Alla kön · Uppdaterad 28 nov. 2025 · NCT06638294

The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI

  • Georgetown University, Washington D.C.
Rekryterar
Ålder 18 till 74 · Kvinnor · Uppdaterad 30 sep. 2025 · NCT06892275

CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing

  • Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
RekryterarFriska volontärer välkomna
Ålder 18 och äldre · Kvinnor · Uppdaterad 28 aug. 2025 · NCT05130606

CtDNA Based MRD Testing for NAC Monitoring in TNBC

  • George Washington University, Washington D.C.
RekryterarObservationsstudie
Ålder 18 och äldre · Kvinnor · Uppdaterad 7 jan. 2025 · NCT06230185

Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.